Compare ONBPO & YDESW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ONBPO | YDESW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2012 | 2024 |
| Metric | ONBPO | YDESW |
|---|---|---|
| Price | $23.29 | $0.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.2K | 4.9K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.55 | N/A |
| EPS | ★ 1.90 | N/A |
| Revenue | ★ $125,616,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.53 | ★ N/A |
| Revenue Growth | ★ 6.07 | N/A |
| 52 Week Low | $23.80 | $0.19 |
| 52 Week High | $25.43 | $1.80 |
| Indicator | ONBPO | YDESW |
|---|---|---|
| Relative Strength Index (RSI) | 23.56 | 46.85 |
| Support Level | N/A | $0.38 |
| Resistance Level | $25.18 | $0.80 |
| Average True Range (ATR) | 0.30 | 0.07 |
| MACD | -0.14 | -0.01 |
| Stochastic Oscillator | 26.88 | 34.96 |
Old National Bancorp is a provider of lending and deposit services. The bank offers comprehensive wealth management, trust, investment advisory, brokerage, and foreign currency services. For businesses, it provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions intended to produce jobs and revitalize its communities. It earns interest income on loans as well as fee income from the origination of loans and from providing other services to its clients.
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.